Advertisement

The Latest

Boston (Mass.) Children’s Hospital has launched a neurologic drug research program through a new research agreement focused on developing therapies for patients with unmet medical needs. The agreement builds on a strategic collaboration announced in July 2025 with NS Pharma,…

In April, President Donald Trump nominated Erica Schwartz, MD, to serve as CDC director. On June 16, she outlined steps to cut ties with her employer, UnitedHealth Group. As recently as May 2025, Dr. Schwartz serves as UnitedHealthcare’s president of…

UPMC Williamsport (Pa.) has completed a newly renovated and relocated interventional radiology suite backed by an investment of more than $8 million, according to a June 23 report from The Standard-Journal. The upgraded suite includes two interventional radiology labs equipped…

Throughout 2026, hospitals and health systems have continued to look inward when searching for a new CEO, with internal promotions spanning operations, finance and clinical leadership. The COO remains a common steppingstone to the top job, consistent with trends Becker’s…

A few citations from CMS-approved accrediting organizations have grown sharply in prevalence, while a long list of others has faded.  For decades, accreditors have surveyed and cited hospitals for deficiencies in care and operations. Over the last eight years, one…

Major drugmakers are advancing therapies that could affect hospital formularies, oncology programs, infectious disease management and obesity care. Here are six recent pharma developments healthcare leaders should know.  Here are six recent moves to know:

Advertisement